epa08503739 A chemist displays the Fabiflu tablets at his medical store in Mumbai, India, 23 June 2020. According to media reports, Glenmark Pharmaceuticals launched antiviral drug Favipiravir – under its brand name Fabiflu, an oral medication approved by the Drugs Controller General of India, used for the treatment of mild to moderate COVID-19 patients. EPA/DIVYAKANT SOLANKI
